Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,064 Hematology
clinical trials

Hematology Clinical Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Hemophilia A Clinical Trial
Safety and Dose Escalation Study of an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia A Subjects
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Madrid,
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Seoul,
Click here to add this to my saved trials
CAH - Congenital Adrenal Hyperplasia Clinical Trial
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Gainesville, FL
Click here to add this to my saved trials
Hematology Clinical Trial
A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Leukemia, Myeloid, Acute Clinical Trial
A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Kansas City, MO
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Nashville, TN
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Middletown, NJ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Acute Myelogenous Leukemia Clinical Trial
Epigenetic Reprogramming in Relapse/Refractory AML
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Randwick,
Click here to add this to my saved trials
AL Amyloidosis Clinical Trial
Ixazomib Maintenance Study in Patients With AL Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Montvale, NJ
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Detroit, MI
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 7: Hemophilia Natural History Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Toledo, OH
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Garden City, KS
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Great Bend, KS
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Livonia, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
London, KY
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ontario, OR
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Warren, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Hemophilia B Clinical Trial
Six Month lead-in Study to Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Aurora, CO
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Charlotte, NC
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Detroit, MI
Click here to add this to my saved trials
Hematology Clinical Trial
A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
San Diego, CA
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Clinical Benefit of SAR650984, Bortezomib, Lenalidomide and Dexamethasone Combination in NDMM Patients Not Eligible for Transplant
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Clinical Benefit of SAR650984, Bortezomib, Lenalidomide and Dexamethasone Combination in NDMM Patients Not Eligible for Transplant
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Kansas City, MO
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Glenwood Springs, CO
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Riverside, CA
Click here to add this to my saved trials
Relapsed or Refractory Multiple Myeloma Clinical Trial
A Study of Carfilzomib Plus Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Relapsed/ Refractory Multiple Myeloma Clinical Trial
Study Evaluating AMG 424 in Subjects With Multiple Myeloma
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Camperdown,
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Canton, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Caro, MI
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Decatur, IL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Fairfax, VA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Downey, CA
Click here to add this to my saved trials
Relapsed/Refractory Acute Myeloid Leukemia (AML) Clinical Trial
Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia.
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Duarte, CA
Click here to add this to my saved trials
Relapsed/Refractory Acute Myeloid Leukemia (AML) Clinical Trial
Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia.
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Mineola, NY
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Portland, OR
Click here to add this to my saved trials
Myelodysplastic Syndrome (MDS) Clinical Trial
Expanded Access for CC-486
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Summit, NJ
Click here to add this to my saved trials
Neoplasms Clinical Trial
Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukaemia (AML)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
mi
from
Toronto,
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Endocrinology, Hematology Clinical Trial
Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
San Diego, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Multiple Myeloma, NHL, and AML
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Buffalo, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Multiple Myeloma, NHL, and AML
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Woolloongabba,
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Charleston, SC
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Hematology Clinical Trial
A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Newark, NJ
Click here to add this to my saved trials
Gastroenterology, Hematology, Oncology Clinical Trial
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Harrison, NY
Click here to add this to my saved trials
Gastroenterology, Hematology, Oncology Clinical Trial
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Gastroenterology, Hematology, Oncology Clinical Trial
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Uniondale, NY
Click here to add this to my saved trials
Fabry Disease Clinical Trial
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Birmingham, AL
Click here to add this to my saved trials
Fabry Disease Clinical Trial
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Fairfax, VA
Click here to add this to my saved trials
Chronic Graft-Versus-Host-Disease Clinical Trial
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Farmington, CT
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
San Francisco, CA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Caldwell, ID
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Swansea, IL
Click here to add this to my saved trials
Hematology Clinical Trial
IMG-7289 in Patients With Myelofibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Adelaide,
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Fabry Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Buenos Aires,
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Fabry Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Chicago, IL
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Fabry Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Manhasset, NY
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Fabry Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Sacramento, CA
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Fabry Disease Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Springfield, MA
Click here to add this to my saved trials
Fabry Disease Clinical Trial
A Study of the Effects of Fabrazyme (Agalsidase Beta) on Mother's Lactation and on the Growth, Development and Immunologic Response of Their Infants
Status: Enrolling, Phase IV
Updated: 10/27/2015
mi
from
Dallas, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Research Tissue Bank
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Bergamo,
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Charleston, WV
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Miami, FL
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Hematology, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Caldwell, ID
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Kidney Tumors in Younger Patients
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Charleston, WV
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Kidney Tumors in Younger Patients
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Kidney Tumors in Younger Patients
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Miami, FL
Click here to add this to my saved trials
Haemophilia A Clinical Trial
BAY81-8973 Pediatric Safety and Efficacy Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Charleston, SC
Click here to add this to my saved trials
Haemophilia A Clinical Trial
BAY81-8973 Pediatric Safety and Efficacy Trial
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Greenville, NC
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Orlando, FL
Click here to add this to my saved trials
Pediatric Acute Myelogenous Leukemia (AML) Clinical Trial
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Status: Enrolling
Updated: 12/6/2012
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Pediatric Acute Myelogenous Leukemia (AML) Clinical Trial
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Status: Enrolling
Updated: 12/6/2012
mi
from
Portland, OR
Click here to add this to my saved trials
Acute Myelogenous Leukemia (AML) Clinical Trial
Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649)
Status: Enrolling, Phase I
Updated: 4/24/2014
mi
from
Rochester, MN
Click here to add this to my saved trials
Acute Myelogenous Leukemia (AML) Clinical Trial
Study of MK-8242 Alone and in Combination With Cytarabine in Participants With Acute Myelogenous Leukemia (P07649)
Status: Enrolling, Phase I
Updated: 4/24/2014
mi
from
Tampa, FL
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
mi
from
Birmingham, AL
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
mi
from
Honolulu, HI
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
mi
from
Iowa City, IA
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
mi
from
La Jolla, CA
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
mi
from
Nashville, TN
Click here to add this to my saved trials